Consun Pharmaceutical Group Limited (HKG:1681)

Hong Kong · Delayed Price · Currency is HKD

16.28

-0.72 (-4.24%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Elimination of Inter-segment Revenue	-7.12M	-	-	-	-
Yulin Pharmaceutical Segment	442.84M	395.06M	358.60M	311.68M	253.71M
Yulin Pharmaceutical Segment Growth	12.09%	10.17%	15.05%	22.85%	-21.77%
Consun Pharmaceutical Segment	2.53B	2.20B	1.98B	1.73B	1.50B
Consun Pharmaceutical Segment Growth	15.33%	10.80%	14.31%	15.60%	6.78%
Total	2.97B	2.59B	2.34B	2.04B	1.75B
Total Growth	14.56%	10.71%	14.43%	16.65%	1.42%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
People's Republic of China (PRC)	2.97B	2.59B	2.34B	2.04B	1.75B
People's Republic of China (PRC) Growth	14.56%	10.71%	14.43%	16.65%	1.42%
Total	2.97B	2.59B	2.34B	2.04B	1.75B
Total Growth	14.56%	10.71%	14.43%	16.65%	1.42%

Source: S&P Global Market Intelligence.